Form4insider filings, from the source

SEC Form 4 · accession 0001179110-15-007021

KYTHERA BIOPHARMACEUTICALS INC · KYTH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Keith R Leonard
Officer — President & CEO · Director
Period of report
May 1, 2015
Accepted (ET)
May 4, 2015 · 4:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001436304

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF7,F2May 1, 2015S600$46.412D862,473ISee footnote
Common StockF8,F2May 1, 2015S8,532$45.351D853,941ISee footnote
Common StockF9,F2May 1, 2015S1,100$44.262D852,841ISee footnote
Common StockF10,F2May 1, 2015S2,768$43.562D850,073ISee footnote
Common StockF3holding———47,103ISee footnote
Common StockF4holding———47,103ISee footnote
Common StockF5holding———189ISee footnote
Common StockF6holding———189ISee footnote
Common Stockholding———9,105D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses